BioFi AG
Thomas Nirnberger is currently the CEO at BioFi AG, where Thomas specializes in drug & biomarker discovery, bioengineering & synthetic biology, and biological computing. Thomas previously worked as the Manager International Markets at Basel Area Business & Innovation and as a Consultant & Operations Lead at MediPaCe. Thomas also has experience at AstraZeneca as a Global Category Manager and Global Sourcing Manager in the Medical Affairs department. With a background in molecular biotechnology and a Master's degree in Medical Informatics, Thomas has a diverse skill set in the healthcare industry.
This person is not in any teams
BioFi AG
At BioFi we are re-imagining virtual biology by building category defining technology from the ground up. Our proprietary technology Endogenics™ is a novel approach to virtual modeling and simulation for living organisms, enabling virtual experimentation in a way that was not possible before. From simple single cells to complex and dynamic multicellular systems, like tissues.